Advisors Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-921
| Closed | -$584K | – | 532 |
|
|
2025
Q1 | $584K | Sell |
921
-801
| -47% | -$508K | 0.01% | 341 |
|
|
2024
Q4 | $1.23M | Sell |
1,722
-35
| -2% | -$24.9K | 0.02% | 281 |
|
|
2024
Q3 | $1.85M | Buy |
1,757
+174
| +11% | +$183K | 0.03% | 252 |
|
|
2024
Q2 | $1.67M | Buy |
1,583
+8
| +0.5% | +$8.41K | 0.03% | 260 |
|
|
2024
Q1 | $1.52M | Buy |
1,575
+2
| +0.1% | +$1.93K | 0.03% | 263 |
|
|
2023
Q4 | $1.38M | Buy |
1,573
+1,181
| +301% | +$1.04M | 0.03% | 269 |
|
|
2023
Q3 | $323K | Sell |
392
-3
| -0.8% | -$2.47K | 0.01% | 348 |
|
|
2023
Q2 | $284K | Buy |
395
+14
| +4% | +$10.1K | 0.01% | 373 |
|
|
2023
Q1 | $313K | Buy |
381
+4
| +1% | +$3.29K | 0.01% | 365 |
|
|
2022
Q4 | $272K | Sell |
377
-3
| -0.8% | -$2.16K | 0.01% | 389 |
|
|
2022
Q3 | $282K | Buy |
380
+7
| +2% | +$5.2K | 0.01% | 396 |
|
|
2022
Q2 | $220K | Sell |
373
-2
| -0.5% | -$1.18K | 0.01% | 407 |
|
|
2022
Q1 | $262K | Buy |
+375
| New | +$262K | 0.01% | 386 |
|